Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
No Data
BKYI Transcript
BIO-key International, Inc. (BKYI) Q3 2025 Earnings Call Transcript
Unknown11-14
The earnings call presents a mixed picture. Financial performance shows a slight decline in gross margin and increased net loss, but cash position improved significantly. Product development is positive with new contracts and high-quality offerings. Market strategy is strong with potential expansions and partnerships. However, flat revenues and management's vague responses in the Q&A raise concerns. The strategic plan indicates optimism for future growth, but immediate financial metrics and unclear guidance limit positive sentiment. Overall, the stock reaction is likely neutral in the short term, balancing positive long-term prospects with current challenges.
BIO-key International, Inc. (BKYI) Q2 2025 Earnings Conference Call Transcript
Positive8-13
The earnings call highlights strong revenue growth (49% increase), reduced SG&A expenses, and a significant reduction in note payable. Despite a slight decline in gross margin, the overall financial performance is robust. The Q&A section reveals confidence in future growth, especially in defense and cybersecurity markets. Although management avoided specific guidance, the positive contract activity and expected breakeven achievement provide a positive outlook. The lack of market cap data suggests a neutral to positive reaction, but given the strong financials and growth prospects, a positive sentiment is warranted.
BIO-key International, Inc. (NASDAQ:BKYI) Q1 2025 Earnings Call Transcript
Unknown5-20
The earnings call shows mixed results: a decline in gross profit and an increase in net loss, but strong hardware revenue growth and a reduced note payable. The Q&A reveals uncertainty about future revenue from large contracts and unclear management responses. Despite strong partnerships and expanding customer base, the lack of guidance and reduced gross margins temper optimism. Without market cap data, it's challenging to predict volatility, but overall sentiment leans neutral given the balance of positive and negative factors.
Earnings call transcript: BIO-key Sees Q1 2025 Revenue Growth Amid Challenges
Unknown5-16
The earnings call presents a mixed picture: positive developments include a reduction in debt, increased cash position, recurring revenue stability, and new contracts. However, there are concerns over declining gross margins, increased losses, and management's reluctance to provide specific guidance. The Q&A section highlights potential growth opportunities but also reveals uncertainties about future revenue streams. Without a clear market cap, the overall sentiment remains neutral, as positive aspects are offset by financial and strategic uncertainties.
BKYI Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
